首页> 外国专利> COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DEGENERATIVE MITRAL VALVE DISEASE IN A CANINE

COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING DEGENERATIVE MITRAL VALVE DISEASE IN A CANINE

机译:在犬诊断和治疗退化二尖瓣病的组合物和方法

摘要

The present invention relates to methods and compositions for diagnosing and treating degenerative mitral valve disease in a canine. In one embodiment, a method of diagnosing early stage degenerative mitral valve disease in a canine can comprise measuring a normalized relative abundance of a biomarker selected from the group consisting of Erysipelatoclostridium, Ruminococcaceae UCG014, Butyricicoccus, Faecalibacterium, and combinations thereof, and determining that the canine has early stage degenerative mitral valve disease if the Erysipelatoclostridium is from 0 to 0.5 normalized relative abundance, the Ruminococcaceae UCG014 is from 0 to 0.1 normalized relative abundance, the Butyricicoccus is from 0 to 0.1 normalized relative abundance, or the Faecalibacterium is from 0 to 0.1 normalized relative abundance.
机译:本发明涉及用于在犬诊断和治疗退行性二尖瓣病的方法和组合物。 在一个实施方案中,在犬诊断早期退化二尖瓣病的方法可包括测量选自肠杆菌菌,喇叭杆菌,粪便,粪杆菌及其组合的归一化的相对丰度,所述生物标志物选自肠球菌曲霉菌,牛肝菌,粪便杆菌及其组合,并确定所述 犬具有早期退行性二尖瓣疾病,如果红细胞曲线杆菌的归一化相对丰度为0至0.5,则喇叭杆菌菌UCG014为0至0.1标准化相对丰度,丁氏菌属为0至0.1标准化的相对丰度,或粪便杆菌为0至0.1 0.1标准化的相对丰度。

著录项

  • 公开/公告号EP3902928A2

    专利类型

  • 公开/公告日2021-11-03

    原文格式PDF

  • 申请/专利权人 SOCIÉTÉ DES PRODUITS NESTLÉ S.A.;

    申请/专利号EP20190835781

  • 发明设计人 LI QINGHONG;

    申请日2019-12-17

  • 分类号C12Q1/689;A23K10/16;A23K50;

  • 国家 EP

  • 入库时间 2022-08-24 22:03:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号